0001415889-20-002946.txt : 20201216
0001415889-20-002946.hdr.sgml : 20201216
20201216191847
ACCESSION NUMBER: 0001415889-20-002946
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201214
FILED AS OF DATE: 20201216
DATE AS OF CHANGE: 20201216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schueren Robert Alan
CENTRAL INDEX KEY: 0001597341
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 201393797
MAIL ADDRESS:
STREET 1: 7400 PASEO PADRE PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
form4-12162020_041235.xml
X0306
4
2020-12-14
0001604821
Natera, Inc.
NTRA
0001597341
Schueren Robert Alan
C/O NATERA, INC.
201 INDUSTRIAL ROAD SUITE 410
SAN CARLOS
CA
94070
false
true
false
false
CHIEF OPERATING OFFICER
Common Stock
2020-12-14
4
M
0
10000
13.01
A
62855
D
Common Stock
2020-12-14
4
S
0
400
97.375
D
62455
D
Common Stock
2020-12-14
4
S
0
440
99.2855
D
62015
D
Common Stock
2020-12-14
4
S
0
11640
100.0132
D
50375
D
Common Stock
2020-12-14
4
S
0
2605
101.4811
D
47770
D
Common Stock
2020-12-14
4
S
0
4915
102.207
D
42855
D
Stock Option (right to buy)
13.01
2020-12-14
4
M
0
10000
0
D
2029-01-10
Common Stock
10000
67500
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.00 to $97.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.67 to $99.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.84 to $100.72 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.915 to $101.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.94 to $102.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2020-12-16